Biphasic (5-2%) oxygen concentration strategy significantly improves the usable blastocyst and cumulative live birth rates in in vitro fertilization.
Sophie Brouillet, Chloé Baron, Fatima Barry...
https://pubmed.ncbi.nlm.nih.gov/34789773/Actively Recruiting
Led by The First Affiliated Hospital with Nanjing Medical University · Updated on 2026-06-01
980
Participants Needed
6
Research Sites
21 weeks
Total Duration
This research aims to compare two oxygen concentration protocolsconstant 5% versus sequential 5%-2%used during embryo culture in assisted reproductive technology. The study focuses on women undergoing blastocyst transplantation to evaluate differences in term live birth rates and offspring health, including potential effects on telomere length, which is linked to aging and health outcomes. The trial is conducted across five centers, including the Clinical Center of Reproductive Medicine at the First Affiliated Hospital of Nanjing Medical University. Participants are randomly assigned to one of two groups one receives embryo culture under a constant 5% oxygen concentration, and the other under a sequential protocol reducing from 5% to 2%. Both groups follow their respective blastocyst culture protocols during in vitro fertilization or intracytoplasmic sperm injection cycles. The study monitors outcomes related to live births and health status of offspring associated with each oxygen protocol. Women enrolled in the trial will be followed for three years, during which live birth rates, clinical pregnancy rates, implantation rates, miscarriage rates, and ectopic pregnancy rates will be recorded. Researchers will also assess offspring health by measuring peripheral blood telomere length. Evaluations include monitoring pregnancy outcomes and any perinatal complications. Data will be statistically analyzed to determine the effects of oxygen concentration protocols on reproductive success and offspring well-being.
CONDITIONS
A Multicenter Prospective Randomized Controlled Clinical Trial Comparing Constant (5%) Versus Sequential (5%-2%) Oxygen Concentration Embryo Culture Protocols in Assisted Reproductive Technology
X
Xiang Ma
H
Haofeng Wang
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
The First Affiliated Hospital with Nanjing Medical University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to embryo transfer and pregnancy confirmation period
Participants receive either constant (5%) or sequential (5%-2%) oxygen concentration protocols during embryo culture as part of assisted reproductive technology.
Visits aligned with embryo culture and transfer procedures
Duration - Up to 3 years
Participants and offspring are followed to assess term live birth rates, offspring health outcomes, and pregnancy outcomes.
Periodic visits for health assessments over 3 years
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Sophie Brouillet, Chloé Baron, Fatima Barry...
https://pubmed.ncbi.nlm.nih.gov/34789773/Deepavali Chakravarti, Kyle A LaBella, Ronald A DePinho
https://pubmed.ncbi.nlm.nih.gov/33450206/Carlos López-Otín, Maria A Blasco, Linda Partridge...
https://pubmed.ncbi.nlm.nih.gov/36599349/Cheng Wang, Yayun Gu, Jun Zhou...
https://pubmed.ncbi.nlm.nih.gov/36522605/N De Munck, R Janssens, I Segers...
https://pubmed.ncbi.nlm.nih.gov/30576441/Daniel J Kaser, Berhan Bogale, Vishnudas Sarda...
https://pubmed.ncbi.nlm.nih.gov/29935641/The First Affiliated Hospital with Nanjing Medical University
Lead Sponsor